Show simple item record

dc.contributor.authorVelema, Men_US
dc.contributor.authorde Nooijer, Aen_US
dc.contributor.authorHermus, Aen_US
dc.contributor.authorTimmers, HJLMen_US
dc.contributor.authorLenders, Jen_US
dc.contributor.authorHusson, Oen_US
dc.contributor.authorDeinum, Jen_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2019-04-17T10:11:05Z
dc.date.issued2019-03-01en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/30865926en_US
dc.identifierEC-19-0026.R2en_US
dc.identifier.citationEndocr Connect, 2019en_US
dc.identifier.issn2049-3614en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3191
dc.identifier.doi10.1530/EC-19-0026en_US
dc.description.abstractOBJECTIVE: To develop a primary aldosteronism (PA) disease-specific Health-Related Quality of Life (HRQoL) questionnaire. METHODS: We included newly diagnosed patients with PA (n=26), and patients with PA after adrenalectomy (n=25) or treated with mineralocorticoid receptor antagonists (n=25). According to the guidelines for developing HRQoL questionnaires from the European Organization for Research and Treatment of Cancer (EORTC): Phase I: systematic literature review followed by focus group meetings with patients (n=13) resulting in a list of 94 HRQoL issues. Relevance of issues was rated by 18 other patients and by health care professionals (n=15), resulting in 30 remaining issues. Phase II: selected issues were converted into questions. Phase III: the provisional questionnaire was pre-tested by a third group of patients (n=45) who also completed the EORTC core quality of life questionnaire (QLQ-C30). Psychometric testing resulted in a final selection of questions with their scale structure. RESULTS: After the collection and selection of HRQoL issues a provisional questionnaire consisting of 30 items was formed. Of these items, 26 could be assigned to one of the four scales 'physical and mental fatigue', 'anxiety and stress', 'fluid balance' and 'other complaints' cumulatively accounting for 68% of variation in all items. All scales had good reliability and validity. There was a significant correlation of all four scales with the QLQ-C30 in most cases. CONCLUSIONS: We developed the first PA-specific HRQoL questionnaire (PA-QoL) using standard, methodologically proven guidelines. After completion of the final validation (phase IV, international field testing), the questionnaire can be implemented into clinical practice.en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.titleA disease-specific quality of life questionnaire for primary aldosteronism.en_US
dc.typeJournal Article
dcterms.dateAccepted2019-03-13en_US
rioxxterms.versionofrecord10.1530/EC-19-0026en_US
rioxxterms.licenseref.startdate2019-03-01en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfEndocr Connecten_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.publication-statusPublished onlineen_US
pubs.embargo.termsNot knownen_US
icr.researchteamClinical and Translational Sarcomaen_US
dc.contributor.icrauthorHusson, Olgaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0